Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients.

By Brandon L. Pierce, R. Ballard-Barbash, L. Bernstein, R. Baumgartner, M. Neuhouser, M. Wener, K. Baumgartner, F. Gilliland, Bess E. Sorensen, A. McTiernan and 1 more. Journal of Clinical Oncology, 2009

681 citations recorded by the source corpus.

Subfields: Cancer Research, Oncology

View Paper: https://www.semanticscholar.org/paper/14d5f817cded92e7a6ddca0c30f6594d5a29d204

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

In Oncology

Citations in the corpus

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration (2012, neutral): “” [163]”
Inflammation: The Common Pathway of Stress-Related Diseases (2017, background): “Circulating levels of IL-6 have been reported as forecast cytokine of survival and metastasis in human cancers (Chung and Chang, 2003; Salgado et al., 2003; Pierce et al., 2009).”
Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice (2018, background): “In breast cancer survivors, elevated plasma levels of C-reactive protein, a nonspecific marker of chronic inflammation, are associated with reduced disease-free survival (8), suggesting that inflammation may play a role in the switch between dormancy and metastasis.”
Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies (2014, background): “possible interaction between leptin and insulin[12], and obesityrelated markers of inflammation[13] have also been linked to breast cancer outcomes.”
Why Sleep Is Important for Health: A Psychoneuroimmunology Perspective (2014, background): “In addition, inflammation appears to be a prognostic factor predicting breast cancer recurrence (Cole 2009, Pierce et al. 2009).”
An epigenetic switch involving NF-κB, Lin28, let-7 microRNA, and IL6 links inflammation to cell transformation (2009, positive): “Clinical and epidemiological studies have suggested a strong association between inflammation and different types of cancer, and inflammatory molecules can provide growth signals that promote the proliferation of malignant cells (Balkwill and Mantovani, 2001; Naugler and Karin, 2008; Pierce et al., ”
Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. (2010, background): “(2010) 6(1) 156 future science group following diagnosis in a large multicenter study in the USA (n = 734) [96].”